Quest Diagnostics (DGX) Adds $1B to Buyback Plan
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $235.46 -0.02%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.5%
EPS Growth %: +10.0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.5%
EPS Growth %: +10.0%
Join SI Premium – FREE
Quest Diagnostics Incorporated (NYSE: DGX),announced that its Board of Directors increased the company's share repurchase authorization by $1 billion. This action increases the current share repurchase authorization to $1.1 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Motorola Solutions raises share buyback program by $2 billion
- Herbalife board approves $250M share buyback over three years
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
